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ABSTRACT
Objective: The purpose of this study was to assess the effects of hyperbaric oxygen (HBO) and near-infrared
light therapy on wound healing. Background Data: Light-emitting diodes (LED), originally developed for
NASA plant growth experiments in space show promise for delivering light deep into tissues of the body to pro-
mote wound healing and human tissue growth. In this paper, we review and present our new data of LED
treatment on cells grown in culture, on ischemic and diabetic wounds in rat models, and on acute and chronic
wounds in humans. Materials and Methods: In vitro and in vivo (animal and human) studies utilized a variety
of LED wavelength, power intensity, and energy density parameters to begin to identify conditions for each bi-
ological tissue that are optimal for biostimulation. Results: LED produced in vitro increases of cell growth of
140–200% in mouse-derived fibroblasts, rat-derived osteoblasts, and rat-derived skeletal muscle cells, and in-
creases in growth of 155–171% of normal human epithelial cells. Wound size decreased up to 36% in conjunc-
tion with HBO in ischemic rat models. LED produced improvement of greater than 40% in musculoskeletal
training injuries in Navy SEAL team members, and decreased wound healing time in crew members aboard a
U.S. Naval submarine. LED produced a 47% reduction in pain of children suffering from oral mucositis. Con-
clusion: We believe that the use of NASA LED for light therapy alone, and in conjunction with hyperbaric oxy-
gen, will greatly enhance the natural wound healing process, and more quickly return the patient to a prein-
jury/illness level of activity. This work is supported and managed through the NASA Marshall Space Flight
Center–SBIR Program.
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INTRODUCTION
THE NEED TO CARE for a population with chronic wounds is agrowing challenge that requires innovative approaches.
Two approaches that specifically address the identified patho-
physiological processes involved in wound healing are hyper-
baric oxygen (HBO) therapy and light therapy. HBO therapy is
currently the standard of care for ischemic, hypoxic, infected,
and otherwise slowly healing, problem wounds. We believe
that the use of NASA light-emitting diodes (LED) for light
therapy alone, and in conjunction with HBO, will greatly en-
hance the natural wound healing process. This will save valu-
able time and resources for both patients and health care facili-
ties. Furthermore, improved wound healing will reduce the risk
of infection for the patient, decrease the amount of costly dress-
ings required, and more quickly return the patient to a prein-
jury/illness level of activity.
Laser light and HBO have been widely acclaimed to speed
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wound healing of ischemic, hypoxic, and infected wounds.1
Lasers provide low-energy stimulation of tissues that results in
increased cellular activity during wound healing.2,3
These activities include collagen production and angiogene-
sis.4 HBO therapy, which is currently standard therapy in the
treatment of diabetic ulcers, graft failures, radiation necrosis,
and other ischemic wounds, has also been shown to beneficially
affect these processes. However, there are a variety of instances
in which a patient who may benefit from HBO is unable or un-
willing to be treated in a high-pressure environment. These sit-
uations include lack of access to a facility equipped with HBO,
claustrophobia, and certain current or chronic medical condi-
tions that would make HBO therapy contraindicated. In these
instances, light therapy provides an alternative for the patient.
Wound healing has three phases: first, a substrate is laid
down, second, cells proliferate, and third, there is remodeling of
tissue. The data published so far suggests that laser biostimula-
tion produces its primary effect during the cell proliferation
phase of the wound healing process. It has been demonstrated
that mitochondria are receptive to monochromatic near-infrared
light and that laser light likely increases respiratory metabolism
of certain cells.2,3,5 Processes such as fibroblast proliferation,
attachment and synthesis of collagen and procollagen, growth
factor production (including keratinocyte growth factor [KGF],
transforming growth factor [TGF], and platelet-derived growth
factor [PDGF]), macrophage stimulation, lymphocyte stimula-
tion,6 and greater rate of extracellular matrix production have
been reported with laser light treatment.7–14 Animal studies on
the enhanced wound healing effect of laser light of low-power
density have been performed in toads, mice, rats, guinea pigs,
and swine.15,16 Human studies with laser light have demon-
strated greater amounts of epithelialization for wound closure
and stimulation of skin graft healing.1,9 An excellent review of
recent human experience with near-infrared light therapy for
wound healing was published by Conlan et al. in 1996.1
Lasers, however, have some inherent characteristics that
make their use in a clinical setting problematic, including limi-
tations in wavelength capabilities and beam width. The com-
bined wavelengths of the light for optimal wound healing can-
not be efficiently produced, the size of wounds that may be
treated is limited (due to laser production of a beam of light—a
fact inconsistent with treating large areas), heat production
from the laser light itself can actually damage tissue, and the
pinpoint beam of laser light can damage the eye. NASA devel-
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FIG. 1. Growth phase specificity of 3T3 fibroblasts; combined wavelengths; 4 J/cm2 versus 8 J/cm2; 50 mW/cm2.
FIG. 2. Growth phase specificity of osteoblasts; individual wavelengths; 8 J/cm2; 50 mW/cm2.
oped LEDs to offer an effective alternative to lasers. These
diodes can be configured to produce multiple wavelengths, can
be arranged in large, flat arrays (allowing treatment of large
wounds), and produce no heat. It is also of importance to note
that LED light therapy has been deemed a nonsignificant risk
by the FDA; thus, FDA approval for the use of LEDs in humans
for light therapy has been obtained.
NASA LEDs stimulate the basic energy processes in the mi-
tochondria (energy compartments) of each cell, particularly
when near-infrared light is used to activate the wavelength sen-
sitive constituents inside (chromophores, cytochrome systems).
Optimal light wavelengths (proven in prior studies of laser and
LED light)2,3,8,11–14,17,18 to speed wound healing include 680,
730, and 880 nm. These wavelengths can be produced accu-
rately by NASA LEDs, which have a bandwidth of 25 nm. The
depth of near-infrared light penetration into human tissue has
been measured spectroscopically.2,3,19 Spectra taken from the
wrist flexor muscles in the forearm and muscles in the calf of
the leg demonstrate that most of the photons at wavelengths of
630–800 nm travel approximately 23 cm through the skin sur-
face (light input) and muscle, exiting at the photon detector.
Data collection and cataloging to elucidate the absorption coef-
ficients of the various human tissues are currently underway by
the principle investigator.
LED IN VITRO STUDIES
In order to understand the effects of LEDs on cell growth and
proliferation, we have measured radiolabeled thymidine incor-
poration in vitro in several cell lines treated with LED light at
various wavelengths and energy levels. As previously reported,
3T3 fibroblasts (mouse-derived skin cells) responded extremely
well to laser and LED light exposure.8,10–13,20,21,22 Cell growth
increased 150–200% over untreated controls. Additionally, os-
teoblasts (rat derived) have been reported to have increased
DNA synthesis and increased cellular growth rate when ex-
posed to laser light.23 With LED treatment, we have found that
these cells demonstrated a growth-phase specificity, responding
only when cells are in the growth phase. In these experiments,
fibroblasts seeded at a concentration of 500 cells/well and os-
teoblasts, seeded at a concentration of 1 3 103 cells/well, were
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FIG. 3. Growth phase specificity of L-6 skeletal muscle cells treated with individual wavelengths at 8 J/cm2; 50 mW/cm2.
FIG. 4. LED response at 4 J/cm2, 50 mW/cm2 using individual wavelengths of 670, 728, and 880 nm (percentage change from
control versus number of hours after LED treatment).
seeded in 12-well plates with a well surface area of approxi-
mately 4 cm2. DNA synthesis was determined on the second,
third, and fourth days in culture for both fibroblasts (Fig. 1) and
osteoblasts (Fig. 2). Exposure to LED irradiation accelerated
the growth rate of fibroblasts and osteoblasts in culture for 2–3
days (growing phase), but showed no significant change in
growth rate for cells in culture at 4 days (stationary phase).
These data are important demonstrations of cell-to-cell contact
inhibition, which occurs in vitro once cell cultures approach
confluence. This is analogous, in vivo, to a healthy organism,
which will regenerate healing tissue, but stop further growth
when healing is complete. It is important to note that LED treat-
ment accelerates normal healing and tissue regeneration with-
out producing overgrowth or neoplastic transformation.
A series of experiments has recently been completed using
an L-6 musculoskeletal cell line (rat derived). These cells were
exposed to the LED light at both combined wavelengths and in-
dividual wavelengths (670, 728, and 880 nm), energy densities
of 4 and 8 J/cm2, and an intensity of 50 mW/cm2. Results
demonstrated a cell growth increase of about 140% over un-
treated controls, particularly at 8 J/cm2 energy, as shown in 
Figure 3.
In addition, experiments are now complete using a normal
human epithelial cell line seeded in 12-well plates at a concen-
tration of 500 cells/well in order to possibly explain the contin-
ued, dramatic results of LED light therapy in preventing oral
mucositis in cancer patients. Cell growth increased 155% over
untreated controls at 670 nm and 4 J/cm2 energy density (50
mW/cm2 power density), as shown in Figure 4. An increase of
171% over untreated controls was obtained with a wavelength
of 880 nm and 8 J/cm2 energy density (53 mW/cm2 power den-
sity), as shown in Figure 5.
Collagen synthesis of the HaCAT epithelial cells was deter-
mined by measuring tritiated proline incorporation using a
modified method described by Peterkofsky and Diegelmann.24
HaCAT epithelial cells were seeded in two 12-well tissue cul-
ture plates with 600 mL DMEM containing 10% FBS, 1% peni-
cillin/streptomycin, and 6 mL L-proline [2,3-3H]. The media
was free of nonessential amino acids. One plate was used as the
control, and the other was treated with the 670-nm NASA LED
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FIG. 5. LED response at 8 J/cm2; 50 mW/cm2 using individual wavelengths of 670, 728, and 880 nm (percentage change from
control versus number of hours after LED treatment).
FIG. 6. HaCAT epithelial cell collagen synthesis at 8 J/cm2, 50 mW/cm2, 670 nm. Shown in 24-h 3H proline incorporation.
at 8 J/cm2. After 24 h of incubation in 5% CO2 at 37°C, two
200-mL aliquots of media were removed from each well. One
aliquot was used to quantitate total protein by trichloroacetic
acid (TCA) precipitation. The precipitated proteins were col-
lected by suction onto a glass fiber filter and allowed to dry
overnight at room temperature. The second aliquot was incu-
bated for 90 min at 37°C with highly purified bacterial collage-
nase that degraded the collagen in the sample. The remaining
noncollagen protein also underwent TCA precipitation. The
following day, scintillation fluid was added and the samples
were counted in a scintillation counter. Collagen content was
determined by subtracting the noncollagen protein from the to-
tal protein. Figure 6 shows that the HaCAT epithelial cells that
were NASA LED treated synthesized more than twice the
amount of collagen than that of the control cells.
LED WOUND HEALING IN RATS
An ischemic wound is a wound in which there is a lack of
oxygen to the wound bed due to an obstruction of arterial blood
flow. Tissue ischemia is a significant cause of impaired wound
healing, which renders the wound more susceptible to infection,
leading to chronic, nonhealing wounds. Despite progress in
wound healing research, there is still very little understanding
of what constitutes a chronic wound, particularly at the molecu-
lar level. Consequently, there is minimal scientific rationale for
treatment.
In order to study the effects of NASA LED technology and
HBO therapy, we developed a model of an ischemic wound in
normal Sprague-Dawley rats. Two parallel, 11-cm incisions
were made 2.5 cm apart on the dorsum of the rats, leaving the
cranial and caudal ends intact. The skin was elevated along the
length of the flap, and two punch biopsies created the wounds
in the center of the flap. A sheet of silicone was placed between
the skin and the underlying muscle to act as a barrier to vascu-
lar growth, thus increasing the ischemic insult to the wounds.
The four groups, each consisting of 15 rats, in this study include
the control (no LED or HBO), HBO only, LED (880 nm) only,
and LED and HBO in combination. The HBO was supplied at
2.4 atm for 90 min, and the LED was delivered at a fluence of 4
J/cm2 and 50 mW/cm2 for 14 consecutive days. A future study
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FIG. 7. Change in wound size in rat ischemic wound model versus time (days).
FIG. 8. Change in vascular endothelial growth factor (VEGF) concentration (mg/mg protein) versus time (days).
will incorporate the combination of three wavelengths (670,
728, and 880 nm) in the treatment groups.
The wounds were traced manually on days 4, 7, 10, and 14.
These tracings were subsequently scanned into a computer,
and the size of the wounds was tracked using SigmaScan Pro
software. Figure 7 depicts the change in wound size over the
course of the 14-day experiment. The combination of HBO
and LED (880 nm) proved to have the greatest effect in wound
healing in terms of this qualitative assessment of wound area.
At day 7, wounds of the HBO and LED (880 nm) group were
36% smaller than those of the control group. That size dis-
crepancy remained by day 10. The LED (880 nm) alone also
speeds wound closure. On day 7, the LED (880 nm) treated
wounds was 20% smaller than the control wounds. By day 10,
the difference between these two groups dropped to 12%. This
was due to the fact that there is a point when the wounds from
all of the groups will be closed. Hence, the early differences
are the most important in terms of determining the optimal ef-
fects of a given treatment. This can be seen at day 14 (Fig. 7),
when the points are converging due to the fact that the wounds
are healing.
Analysis of the biochemical makeup of the wounds at days 0,
4, 7, and 14 was performed. The day 0 time point was deter-
mined by evaluating the punch biopsy samples from the origi-
nal surgery. The levels of basic fibroblast growth factor (FGF-
2) and vascular endothelial growth factor (VEGF) were
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FIG. 9. Change in basic fibroblast growth factor (FGF-2) concentration (mg/mg protein) versus time (days).
FIG. 10. Type 2 diabetic mice with excisional skin wounds treated with combined LED wavelengths, 4 J/cm2, 50 mW/cm2. The
square root of wound area is used in the dependent variable in the analysis. This transformation was needed to correct for noncon-
stant error in the general linear model. SqrtArea could be interpreted as being proportional to the radius of a circular wound.
determined using ELISA (enzyme linked immunosorbent as-
say). The changes in the VEGF concentration throughout the
14-day experiment can be seen in Figure 8. The LED (880 nm)
group experiences a VEGF peak at day 4 much like the control
group. In contrast, the hyperoxic effect of the HBO suppresses
the day 4 peak, and instead, the HBO groups peak at day 7. The
synergistic effect of the HBO and LED (880 nm) can be seen at
day 4. The VEGF level for the group receiving both treatments
is markedly higher at day 4 than the HBO only group. The HBO
and LED (880 nm) treated group also experiences the day 7
peak characterized by the HBO treatment. Hence, there is a
more uniform rise and fall to the VEGF level in the combined
treatment group as opposed to the sudden increases seen in the
control, LED only, and HBO only groups. By day 14, the HBO-
treated groups have dropped closer to the normal level than the
LED (880 nm) only or control groups.
The synergistic effects of HBO and LED (880 nm) can also
be seen easily in Figure 9. The pattern of the changes in basic
fibroblast growth factor (FGF-2) concentration is similar to that
of the VEGF data. It is clear that the LED (880 nm) day 4 peak
is higher than the day 4 peak of the control group. These peaks
can be attributed to the hypoxic effect of the tissue ischemia
created in the surgery. The hyperoxia of the HBO therapy has a
greater effect on suppressing the FGF-2 concentration at day 4
than the VEGF concentration at the same time point. The syn-
ergy of the two treatments is evident when looking at the HBO
and LED (880 nm) treated group. The concentration of FGF-2
at day 4 is significantly enhanced by the LED (880 nm) treat-
ment. Whereas the level would normally drop off by day 7 for a
LED-only treated wound, the HBO effect seizes control, caus-
ing the concentration of FGF-2 to plateau. Hence, an elevated
FGF-2 concentration is achieved throughout the greater part of
the 14-day treatment with both HBO and LED (880 nm) thera-
pies. Further analysis of the excised wounds will include matrix
metalloproteinase 2 and 9 (MMP-2 and MMP-9) determination
by ELISA, histological examination, and RNA extraction.
A wound healing impaired type 2 diabetic mouse model has
also been studied. As previously reported, genetically diabetic
mice treated with low level laser irradiation demonstrated sig-
nificantly enhanced wound closure grossly, and improved
wound epithelialization, cellular content, granulation tissue for-
mation, collagen deposition, and extensive neovascularization
on histological evaluation.21 In our study, type 2 diabetic mice
with excisional skin wounds were treated with LEDs at individ-
ual wavelengths of 680, 730, and 880 nm at 4 J/cm2 and 50
mW/cm2. LED treatment produced increased healing rates,
compared to surgical controls, as seen in Figure 10.
A repeated measures analysis was conducted using a general
linear model with SqrtArea as the dependent variable and Treat
as the independent variable. The interaction effect Day*Treat is
significant (p value5 0.0095), indicating that there is a signifi-
cant difference between treatments on some days. This test is of
primary interest in this situation, because it shows that the treat-
ments are effective for some part of the treatment period (Fig.
10). This analysis was carried out using the SAS statistical soft-
ware package, published by The SAS Institute, Inc.
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FIG. 11. Cumulative results of data from 11 patients (SEALS) showing improvement in range of motion, pain, and girth reported
as percentage change from chronic, unimproving injured baseline after LED treatment at 4 J/cm2, 10 mW/cm2.
TABLE 1. PAIN INTENSITY IN MUCOSITIS PATIENTS IS REDUCED BY LED THERAPY IN CHEEKS COMPARED TO
THROAT (CONTROL = 100%)
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day 9
Control (throat) 100 100 100 100 100 100 100 100 100
Right cheek 98.56 67.81 84.78 79.78 86.16 63.79 52.73 58.65 61.48
Left cheek 104.1 71.21 81.48 82.32 86.82 60.93 53.27 57.48 58.65
Control SEM 33.2 22.9 20.7 18.1 17.8 18.9 21.7 22.6 22.8
Right SEM 34.2 25.2 20.4 23.5 24.5 24.1 17.9 11 18
Left SEM 33.8 24 20.6 24.1 24.3 25.9 17.7 11.1 15.8
LED WOUND HEALING IN HUMAN SUBJECTS
Clinical LED wound healing studies have been reported pre-
viously;11–13 additional data on human trials are summarized
below.
Military Special Operations are characterized by lightly
equipped, highly mobile troops entering situations requiring
optimal physical conditioning at all times. Wounds are an obvi-
ous physical risk during combat operations. Any simple and
lightweight equipment that promotes wound healing and mus-
culoskeletal rehabilitation and conditioning has potential merit.
An LED array with three wavelengths combined in a single unit
(670, 720, and 880 nm) was delivered to Naval Special Warfare
Group–2 (SEALS) in Norfolk, Virginia. Treatment was with 4
J/cm2. A data collection system has been implemented for mus-
culoskeletal training injuries treated with LEDs. Data collection
instruments now include injury diagnosis, day from injury,
range of motion measured with goniometer, pain intensity
scales reported on scale 1–10, girth-circumferential measure-
ments in centimeters, percent changes over time in all of the
aforementioned parameters, and number of LED-treatments re-
quired for the subject to be fit-for-full-duty (FFD). These in-
juries were sustained 1 month to 1 year prior to LED treatment
and had been chronic and unimproving in nature. See summary
of data in Figure 11.
In collaboration with U.S. Navy Submarine Squadron
ELEVEN, data have also been received from the USS Salt Lake
City (submarine SSN 716 of the U.S. Naval Pacific Fleet). Sub-
marine atmospheres are low in oxygen and high in carbon diox-
ide, which compounds the absence of crew exposure to sun-
light, making wound healing slower than on the surface.
Reports indicate a 50% faster healing of lacerations in crew
members treated with a LED array with three wavelengths
combined in a single unit (670, 720, 880 nm) compared to un-
treated control healing (7 days compared to approximately 14
days, respectively). Complete analysis of data is still underway.
Receipt of control data from submarines without LED arrays on
board continues, and another submarine recently deployed from
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FIG. 12. Decrease in pain intensity over time after daily treatment with NASA LED light at 670 nm, 4 J/cm2, 50 mW/cm2.
FIG. 13. The difference between LED-treated (mouth) and untreated control (throat) becomes more dramatic over time, with
daily treatment using NASA LED light at 670 nm, 4 J/cm2, 50 mW/cm2
U.S. Naval Station–San Diego on a 6-month mission is
equipped with a LED snap-light array on board.
In addition, we have recently begun using NASA LEDs to
promote healing of acute oral lesions in pediatric leukemia pa-
tients. As a final life-saving effort, leukemia patients are given
healthy bone marrow from an HLA-matched donor. Prior to the
transplant, the patient is given a lethal dose of chemotherapy in
order to destroy his or her own cancerous bone marrow. Be-
cause many chemotherapeutic drugs, as well as radiation ther-
apy, kill all rapidly dividing cells indiscriminately, the mucosal
linings of the gastrointestinal tract are often damaged during the
treatment. As a result of these gastrointestinal effects, greater
than one-third of patients treated with cytotoxic drugs develop
ulcers in their mouths (oral mucositis) and/or suffer from nau-
sea and diarrhea. Oral mucositis, which causes severe pain,
bleeding, an increased risk for infection, and compromised abil-
ity to chew and swallow, is a significant risk for this population.
Current treatment for mucositis addresses pain management
and infection prevention. The use of oral agents to promote
cleansing, debridement, and comfort are recommended, and
prophylactic oral antiviral and antifungal agents have been used
to minimize infections. Because lasers have been shown to
speed healing of oral mucositis,25,26 we have recently expanded
the wound-healing abilities of LED light therapy to include
these oral lesions.
A 4 J/cm2, 50 mW/cm2 dose of 670-nm light from LEDs was
applied daily to the outside of each patient’s left cheek begin-
ning on the day of bone marrow transplantation. The status of
their oral mucosa, mouth, and throat pain was assessed three
times a week by two calibrated dental clinicians. Each side of
the mouth was scored using the Schubert Oral Mucositis Index
(OMI), the mucosa were photographed, and mouth and throat
pain were assessed using a 1–10 Visual Analog scale.27 We
have now completed treatment to half of our intended patient
population and have noticed some very encouraging trends, but
statistical significance will require more patients, as intended in
our current study design. We have assessed left cheek, right
cheek, and throat pain in each patient, and have noted that there
is no statistical difference in perceived pain on either side of the
mouth, consistent with the expected tissue penetration (23 cm)
of LED light. Throat pain, however, was consistently higher
than mouth pain, and because our light does not extend into this
region, we have used this pain as our control. Although mouth
and throat pain were initially similar, mouth pain peaked at
86% of throat pain on day 5 after transplant and subsequently
fell to only 53% of reported throat pain by day 7 (Table 1, Fig-
ures 12 and 13). The greatest difference between throat and
mouth pain was reported on day 7, when, surprisingly, oral mu-
cosal ulceration is believed to be worst in untreated patients.
Additionally, we are determining extent of ulceration, heal-
ing rate in mm2/day, and healing time in days for these patients,
and we will compare these values with epidemiological control
data. A chart review is also in progress to assess morphine
pump use and requirements for intravenous feedings in LED-
treated patients compared to controls. Contact with the FDA’s
Richard Felten of the General Surgery Devices Branch has pro-
duced an avenue for guidance to final data collection and FDA
approval of this technology as the standard of therapy for treat-
ment of mucositis. FDA review of our current data and protocol
design is ongoing, and has already led to an FDA recommenda-
tion for expanding our study to include at least three more aca-
demic medical centers, in addition to our own, to be supplied
with NASA LED arrays by Quantum Devices, Inc. A multisite
trial is being planned through the International Bone Marrow
Transplant Registry.
RESEARCH COLLABORATION
We are now investigating new collaborations with the De-
fense Advanced Research Projects Agency (DARPA) for fur-
ther military applications of NASA LED wound healing tech-
nology in military medicine. Several uniquely military
situations and indications could be addressed in the new collab-
oration. These include burns, injuries from chemical agents, ra-
diation, highly infected wounds (which are typical for the hy-
gienic conditions occurring in battlefields), infectious diseases,
and external wounds occurring in environments with no solar
irradiation, low oxygen, and high carbon dioxide (submarines
and space environments). The dramatic results with use of near-
infrared NASA LED light to prevent digestive mucosal lesions
(mucositis) and pain in cancer patients, after high-dose
chemotherapy and radiation, suggest the potential for military
use of near-infrared light to treat U.S. troops exposed to chemi-
cal and radioactive warfare agents in the field28 These life-sav-
ing applications require especially accelerated wound healing,
rapid reduction of infections, and pain modulation.
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